Supplementary Figure Legend from Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations

Erick Riquelme,Carmen Behrens,Heather Y. Lin,George Simon,Vassiliki Papadimitrakopoulou,Julie Izzo,Cesar Moran,Neda Kalhor,J. Jack Lee, John D. Minna,Ignacio I. Wistuba

crossref（2023）

引用 0|浏览6

暂无评分

摘要

1.EZH2 and MEK-ERK and PI3K/AKT signaling pathway expression in lung adenocarcinoma and HBEC cell lines and 2. Sensitivity in vitro to AZD6244 and MK2206 in combination with selective EZH2 inhibitor GSK343, EPZ6438 and GSK126 in NSCLC cells.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要